Position in BYSI
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,625
+$165 QoQ
Shares Held
1,500
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 22 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BYSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trifecta Capital Advisors, LLC holds $8,474,760 across 8 Biotechnology names. BYSI ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,745 | $8,317,743 | |
| 2 | DRTS |
Alpha Tau Medical Ltd.
|
8,750 | $110,075 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
2,100 | $37,422 | |
| 4 | ARMP |
Armata Pharmaceuticals, Inc.
|
714 | $4,626 | |
| 5 | BYSI |
BeyondSpring Inc.
This page
|
1,500 | $2,625 | |
| 6 | ARGX |
Argenx SE
|
2 | $1,855 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4 | $227 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
1 | $187 |
All Filings in BYSI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,625 | 1,500 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,460 | 1,500 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,445 | 1,500 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,715 | 1,500 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $3,525 | 1,500 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,152 | 1,500 | Shares | Sole | 2025-04-21 | |
| No filing history on record for this holder in this stock. | ||||||